Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Búsqueda avanzada de patentes | Historial web | Iniciar sesión

Patentes

Citada por

Patente citante Fecha de presentación Fecha de emisión Cesionario original Título
US395174811 Nov 197420 Abr 1976Medical Products, Inc.Sensitized matrix for detection of disease
US40160434 Sep 19755 Abr 1977Akzona IncorporatedEnzymatic immunological method for the determination of antigens and antibodies
US403965211 Oct 19732 Ago 1977Miles Laboratories, Inc.Column method of immunoassay employing an immobilized binding partner
US411677619 Abr 197626 Sep 1978International Radioimmune Systems, Inc.Diagnostic blood test and kit for detecting human chorionic gonadotropin
US42005089 Feb 197829 Abr 1980Method and composition for detecting antigenic substances
US42038025 Dic 197720 May 1980Syva CompanyInhibitable enzyme amplification assay
US42407519 Nov 197823 Dic 1980Akzona IncorporatedMethod and apparatus for specific binding substances
US42489653 Oct 19773 Feb 1981Mochida Seiyaku Kabushiki KaishaImmunochemical process of measuring physiologically active substances
US425422316 Abr 19793 Mar 1981Akzona IncorporatedApparatus for colorimetric determination
US42699388 Mar 197926 May 1981Eastman Kodak CompanyAssay of peroxidatively active materials
US427514924 Nov 197823 Jun 1981Syva CompanyMacromolecular environment control in specific receptor assays
US428974831 May 197915 Sep 1981United States of AmericaUltrasensitive enzymatic radioimmunoassay method
US43025347 Mar 197824 Nov 1981Israel Institute for Biological ResearchChemiluminescent enzyme immunoassay
US43187073 Jun 19809 Mar 1982Syva CompanyMacromolecular fluorescent quencher particle in specific receptor assays
US432364715 Oct 19806 Abr 1982University of MiamiSteric hindrance enzyme immunoassay
US43314443 Mar 198025 May 1982Fuji Photo Film Co., Ltd.Competitive immunoassay using silver halide fogging agent
US43370633 Mar 198029 Jun 1982Fuji Photo Film Co., Ltd.Competitive immunoassay using spectral sensitizer label
US43438961 May 198010 Ago 1982Akzona IncorporatedMethod and test pack for the demonstration and determination of an antigen or antibody
US436253114 Abr 19817 Dic 1982Technicon Instruments CorporationAgglutination immunoassays carried out with agent to reduce non-specific interferences
US43749259 Feb 198122 Feb 1983Syva CompanyMacromolecular environment control in specific receptor assays
US43761104 Ago 19808 Mar 1983Hybritech, IncorporatedImmunometric assays using monoclonal antibodies
US442427912 Ago 19823 Ene 1984QuidelRapid plunger immunoassay method and apparatus
US444623213 Oct 19811 May 1984Enzyme immunoassay with two-zoned device having bound antigens
US444623825 Ene 19821 May 1984Janssen Pharmaceutica N.V.Bright field light microscopic method of localizing tissue antigens
US445288621 Sep 19815 Jun 1984Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
US446978714 May 19824 Sep 1984Mallinckrodt Inc.Immunoassay involving soluble complex of second antibody and labeled binding protein
US447487829 Sep 19752 Oct 1984Cordis Laboratories, Inc.Sandwich EIA for antigen associated with hepatitis
US448653024 Jun 19814 Dic 1984Hybritech IncorporatedImmunometric assays using monoclonal antibodies
US450314320 Ago 19825 Mar 1985BTC Diagnostics Limited PartnershipEnzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
US450600930 Mar 198219 Mar 1985University of CaliforniaHeterogeneous immunoassay method
US451728823 Ene 198114 May 1985American Hospital Supply Corp.Solid phase system for ligand assay
US453090013 Sep 198223 Jul 1985Seragen Diagnostics Inc.Soluble insoluble polymers in enzymeimmunoassay
US459299516 Nov 19833 Jun 1986Dainippon Pharmaceutical Co., Ltd.Reagent for streptococcal anti-esterase assay
US46043651 Jul 19825 Ago 1986Electro-Nucleonics, Inc.Immunoprecipitation assay
US46422852 May 198410 Feb 1987Diamedix CorporationSandwich EIA for antigen
US466502030 May 198412 May 1987United States Department of EnergyFlow cytometer measurement of binding assays
US471334714 Ene 198515 Dic 1987Sensor Diagnostics, Inc.Measurement of ligand/anti-ligand interactions using bulk conductance
US475387526 Jul 198528 Jun 1988Method for assaying proteases with tagged proteinaceous inhibitors
US480852223 Abr 198628 Feb 1989Moskovsky Gosudarstvennx Universitet Imeni M. V. Lomonoso VAEnzyme immunoassays using inorganic pyrophosphatase
US481239519 Ago 198614 Mar 1989E. I. Du Pont De Nemours and CompanyMethod for detecting enzymatic activity using particle agglutination
US48123962 Jul 198714 Mar 1989E. I. Du Pont De Nemours and CompanyMethod for detecting enzymatic activity using particle agglutination
US48247849 Nov 198725 Abr 1989Hygeia Sciences, IncorporatedChromogenic solution for immunoassay
US486810812 Dic 198519 Sep 1989Hygeia Sciences, IncorporatedMultiple-antibody detection of antigen
US493138521 Nov 19885 Jun 1990Hygeia Sciences, IncorporatedEnzyme immunoassays and immunologic reagents
US50473306 Ene 198810 Sep 1991Commissariat a l'Energie AtomiqueCompound labelled by the acetyl cholinesterase of Electrophorus electricus, its preparation process and its use as a tracer or marker in enzymoimmunological determinations
US510278828 Abr 19897 Abr 1992Hygeia Sciences, Inc.Immunoassay including lyophilized reactant mixture
US532882820 Jul 199212 Jul 1994Syntex (U.S.A.) Inc.Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
US53345133 Sep 19922 Ago 1994Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US534886715 Nov 199120 Sep 1994George GeorgiouExpression of proteins on bacterial surface
US545150710 May 199419 Sep 1995Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US54686471 Sep 199421 Nov 1995Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US553440518 Nov 19949 Jul 1996The Scripps Research InstituteAntibodies, diagnostic systems and methods for assaying HBxAg
US561007719 Jul 199411 Mar 1997Unilever Patent Holdings B.V.Processes and apparatus for carrying out specific binding assays
US561450421 Abr 199525 Mar 1997The University of South FloridaMethod of making inosine monophosphate derivatives and immunopotentiating uses thereof
US56248095 May 199529 Abr 1997Behringwerke AGDevice for immunochromatographic analysis
US567247520 Ene 199530 Sep 1997Chiron Diagnostics CorporationMixed luminescent conjugate test
US569868628 Abr 199516 Dic 1997Arch Development CorporationYeast telomerase compositions
US572601510 Ene 199510 Mar 1998Vanderbilt UniversityMethod to determine metastatic potential of tumor cells
US57260236 Jun 199510 Mar 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US572880721 Jun 199517 Mar 1998Ramot-University Authority For Applied Research and Industrial Development, Ltd. Mutated proteins associated with ataxia-telangiectasia
US577709328 Jul 19957 Jul 1998RAMOT-University Authority for Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US580100531 Mar 19951 Sep 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US58075524 Ago 199515 Sep 1998Board of Regents, The University of Texas SystemCompositions for conferring immunogenicity to a substance and uses thereof
US583753515 Feb 199617 Nov 1998Henry Ford Health SystemNeuronal-neonatal gene: neuronatin
US584032219 Dic 199624 Nov 1998Ramot-University Authority For Applied Research & Industrial Devel. Ltd.Anti-oral-microbial adhesion fraction derived from vaccinium
US58436737 Jun 19951 Dic 1998Curators of the University of MissouriMethod of screening for endometriosis
US58465387 Jun 19958 Dic 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
US58586618 Abr 199612 Ene 1999RAMOT-University Authority for Applied Research and Industrial DevelopmentAtaxia-telangiectasia gene and its genomic organization
US58694451 Abr 19969 Feb 1999University of WashingtonMethods for eliciting or enhancing reactivity to HER-2/neu protein
US587442312 Sep 199623 Feb 1999Yissum Research Development Co. of the Hebrew University of JerusalemDigitalis-like compounds
US58767126 Jun 19952 Mar 1999University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US591675226 Sep 199729 Jun 1999Arch Development CorporationTelomerase screening methods
US60751226 Jun 199513 Jun 2000University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US61875634 Ago 199913 Feb 2001Yale University.beta.IV-spectrin-polypeptides and nucleic acids encoding same
US62007493 May 199613 Mar 2001Ramot-University Authority for Applied Research and Industrial Development Ltd.Mutated forms of the ataxia-telangiectasia gene and method to screen for a partial A-T phenotype
US620075521 Jul 199813 Mar 2001Burstein Technologies, Inc.Optical disk-based assay devices and methods
US62844962 Ene 19984 Sep 2001University of South FloridaDNA vector for determining the presence of out-of-reading-frame mutations
US631290110 Sep 19996 Nov 2001Burstein Technologies, Inc.Spatially addressable, cleavable reflective signal elements, assay device and method
US63312753 Ago 200018 Dic 2001Burstein Technologies, Inc.Spatially addressable, cleavable reflective signal elements, assay device and method
US634234921 Jul 199829 Ene 2002Burstein Technologies, Inc.Optical disk-based assay devices and methods
US63444438 Jul 19995 Feb 2002University of South FloridaPeptide antagonists of tumor necrosis factor alpha
US638761930 Jun 199914 May 2002Arch DevelopmentTelomerase compositions and methods
US63915638 Dic 199321 May 2002Akzo Nobel N.V.Method for the determination of antigens with the aid of three or more monoclonal antibodies
US64069207 Ago 199618 Jun 2002Inverness Medical Switzerland GmbHProcesses and apparatus for carrying out specific binding assays
US644068224 May 200027 Ago 2002Detroit R&D Inc.Detection of hypertension using immunoreactive metabolic products
US64823892 Jun 200019 Nov 2002University of South FloridaMethod to diagnose and monitor cellular immune deficiencies
US653127719 Mar 199811 Mar 2003The Curators of the University of MissouriEndometriosis-specific secretory protein
US661083815 Sep 199826 Ago 2003Symbicom AktiebolagP13 antigens from Borrelia
US665647116 Nov 19992 Dic 2003Board of Regents, The University of Texas SystemHIV-specific T-cell induction
US666437015 Jul 199916 Dic 2003University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US668975728 Dic 199810 Feb 2004M.L. Laboratories PLCMethods for vaccination and vaccines therefor
US674073823 Dic 200225 May 2004Quark Biotech, Inc.Antibody against hypoxia proteins
US67706228 Jun 20013 Ago 2004N-terminally truncated galectin-3 for use in treating cancer
US67873181 Jun 20007 Sep 2004Roskamp Research Institute, LLCAssay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US686700524 Oct 200115 Mar 2005Beckman Coulter, Inc.Method and apparatus for increasing the dynamic range and accuracy of binding assays
US687558218 Ago 20005 Abr 2005OmniScience Pharmaceuticals, Inc.Methods and targets of antibiotic resistance
US69535736 Oct 199811 Oct 2005University of WashingtonCompounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US699217613 Feb 200231 Ene 2006Technion Research & Development Foundation Ltd.Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
US69982324 Abr 200114 Feb 2006Quark Biotech, Inc.Methods of diagnosing bladder cancer
US703374711 Abr 200225 Abr 2006Nagaoka & Co., LTD
Burstein Technologies, Inc.
Multi-parameter assays including analysis discs and methods relating thereto
US70604621 Nov 200113 Jun 2006National University of SingaporeAopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display
US708739516 Ene 20018 Ago 2006Quest Diagnostics Investments IncorporatedVitamin D assay
US710183929 Ago 20005 Sep 2006Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US71381449 Sep 200221 Nov 2006Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
US722390215 Nov 200029 May 2007Yissum Research Development Company of the Hebrew University of JerusalemMethod of producing recombinant Aspergillus niger β-glucosidase and an aroma spreading plant
US724770321 Ago 200324 Jul 2007University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US727081028 Dic 200018 Sep 2007Yeda Research and Development Co. Ltd.Veto cells effective in preventing graft rejection and devoid of graft versus host potential
US72947012 Abr 200313 Nov 2007Technion Research & Development Foundation Ltd.Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
US730680429 Sep 200311 Dic 2007Board of Regents, the University of Texas SystemHIV-specific T-cell induction
US730680429 Sep 200311 Dic 2007Board of Regents, the University of Texas SystemHIV-specific T-cell induction
US734797222 Jul 199825 Mar 2008Multiple analyte assay device
US73550795 Abr 20058 Abr 2008The Regents of the University of California
Oregon Health & Science University
Thyronamine derivatives and analogs and methods of use thereof
US738510610 Ene 200110 Jun 2008Ramot At Tel Aviv University Ltd.Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
US742313920 Ene 20049 Sep 2008InSight Biopharmaceuticals Ltd.High level expression of recombinant human erythropoietin having a modified 5′-UTR
US744278115 Ago 200228 Oct 2008Urifer Ltd.Diagnosis, prevention and treatment of cancer
US749842820 Jun 20043 Mar 2009Evogene Ltd.Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US753460517 May 200519 May 2009Yissum Research Development Company of the Hebrew University of JerusalemCD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US753460911 Abr 200519 May 2009Pluristem Life Systems Inc.Method of expanding undifferentiated hemopoietic stem cells
US75539401 Feb 200730 Jun 2009Modigene IncLong-acting EPO polypeptides and derivatives thereof and methods thereof
US75539411 Feb 200730 Jun 2009Modigene IncLong-acting polypeptides and methods of producing same
US755400722 Nov 200530 Jun 2009Evogene Ltd.Methods of increasing abiotic stress tolerance and/or biomass in plants
US76016973 May 200513 Oct 2009University of WashingtonCompounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US760514913 Jul 199920 Oct 2009University of South FloridaModulation of the phospholipase A2 pathway as a therapeutic
US761172320 Mar 20033 Nov 2009NanoCyte Inc.Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US762570727 Sep 20041 Dic 2009Ramot At Tel Aviv University Ltd.Antibacterial agents and methods of identifying and utilizing same
US763252210 Ene 200615 Dic 2009NanoCyte Inc.Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US76329239 Mar 200515 Dic 2009Technion Research & Development Foundation Ltd.Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US763812425 Mar 200429 Dic 2009Technion Research & Development Foundation Ltd.Antigen-presenting complex-binding compositions and uses thereof
US765522519 Feb 20082 Feb 2010Gamida Cell, Ltd.Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
US765523921 Jun 20072 Feb 2010University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US767857311 Abr 200516 Mar 2010Pluristem Ltd.Method of preparing a conditioned medium from a confluent stromal cell culture
US768705717 Dic 200230 Mar 2010Yissum Research Development Company of the Hebrew University of JerusalemIn vitro micro-organs, and uses related thereto
US769592717 Mar 200613 Abr 2010Detroit R & DDetection of hypertension using glucuronidated metabolic products
US771877718 Oct 200618 May 2010Technion Research & Development Foundation Ltd.MHC-peptide complex binding ligands
US778139621 Jun 200624 Ago 2010Tel Aviv University Future Technology Development L.P.Peptides directed for diagnosis and treatment of amyloid-associated disease
US778140211 Oct 200524 Ago 2010Closed Loop Therapies Ltd.Methods and implantable devices for treating supraventricular arrhythmias
US778626731 Ene 200831 Ago 2010Baylor Research InstituteMultivariable antigens complexed with targeting humanized monoclonal antibody
US779067312 Jun 20067 Sep 2010New York UniversityMethods and compositions relating to cystatin C
US781198129 Sep 200412 Oct 2010Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US785507519 May 200821 Dic 2010Gamida Cell Ltd.
Hadasit Medical Research Services and Development Ltd.
Methods of controlling proliferation and differentiation of stem and progenitor cells
US78880032 Sep 200515 Feb 2011The United States of America as represented by the Department of Health and Human ServicesMethods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
US789324025 Jul 200822 Feb 2011InSight Biopharmaceuticals Ltd.High level expression of recombinant human erythropoietin having a modified 5′-UTR
US791080015 Ago 200622 Mar 2011Evogene Ltd.Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
US792808316 Ene 200819 Abr 2011Yissum Research Development Company of the Hebrew University of JerusalemH19 silencing nucleic acid agents for treating rheumatoid arthritis
US794749930 Nov 200324 May 2011Technion Research & Development Foundation Ltd.Method of dynamically culturing embryonic stem cells
US79558529 Feb 20047 Jun 2011Gamida Cell Ltd.Expansion of renewable stem cell populations
US800090030 Dic 200516 Ago 2011Microsoft CorporationAssociation-based predictions of pathogen characteristics
US80078477 Ago 200630 Ago 2011Eytan BidermanFeeding formula appliance
US80129292 Jul 20096 Sep 2011Tel Aviv University Future Technology Development L.P.Peptides directed for diagnosis and treatment of amyloid-associated diseases
US80175865 Ene 200913 Sep 2011Ramot at Tel-Aviv University Ltd.Peptide nanostructures encapsulating a foreign material and method of manufacturing same
US801981816 Ene 200713 Sep 2011Zlango Ltd.Communications network system and methods for using same
US803491421 Sep 200611 Oct 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
US803924028 Sep 200518 Oct 2011Yissum Reseach Development Company of the Hebrew University of JerusalemRecombinant human T2 RNase and uses thereof
US80535542 Ene 20098 Nov 2011Ramot at Tel-Aviv University Ltd.Peptide nanostructures and methods of generating and using the same
US80577981 Feb 200815 Nov 2011Baylor Research InstituteVaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
US806266015 Mar 200622 Nov 2011NanoCyte Inc.Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US80675736 Jul 200629 Nov 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid agents for downregulating H19 and methods of using same
US806757416 Ene 200829 Nov 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid agents for downregulating H19, and methods of using same
US80713236 Abr 20076 Dic 2011The United States of America as represented by the Secretary of the Department of Health and Human ServicesHuman monoclonal antibodies that bind human insulin like growth factors and their use
US808041729 Nov 200620 Dic 2011Gamida-Cell Ltd.Methods of ex vivo hematopoietic stem cell expansion by co-culture with mesenchymal cells
US80881602 Jun 20093 Ene 2012Multi-Gene Vascular Systems Ltd. (“MGVS”)Drug-eluting intravascular prostheses and methods of use
US81295149 Feb 20096 Mar 2012Evogene Ltd.Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US815338318 Mar 200910 Abr 2012Wisconsin Alumni Research FoundationMycobacterial culture screening test for Mycobacterium avium complex bacteria
US815837114 Oct 201017 Abr 2012Wisconsin Alumni Research FoundationAssay for antibodies to Mycobacterium paratuberculosis
US816349427 Nov 200324 Abr 2012Technion Research & Development Foundation Ltd.Method for assessing metastatic properties of breast cancer
US816818030 Sep 20091 May 2012Technion Research & Development Foundation Ltd.Methods and compositions for modulating angiogenesis
US816885720 Dic 20071 May 2012Evogene Ltd.Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US81781285 Dic 200215 May 2012Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Nanoparticles containing polymeric nucleic acid homologs
US81933117 Feb 20115 Jun 2012Yissum Research Development Company of the Hebrew University of JerusalemCD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US82027246 Oct 201019 Jun 2012Gamida Cell Ltd.
Hadasit Medical Research Services and Development Ltd.
Methods of controlling proliferation and differentiation of stem and progenitor cells
US823654327 Sep 20107 Ago 2012Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US82369342 Feb 20087 Ago 2012Baylore Research InstituteAgents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
USRE310062 Mar 19783 Ago 1982Akzona IncorporatedProcess for the demonstration and determination of reaction components having specific binding affinity for each other
USRE3269622 Dic 197814 Jun 1988Akzona IncorporatedEnzymatic immunological method for determination of antigens and antibodies